HeartMate 3 LVAS
ABBOTT MEDICAL · Decision date Oct 1, 2026
What did the FDA decide?
The supplied FDA record identifies supplement S135 to PMA P160054 for HeartMate 3 LVAS, filed by Abbott Medical under product code DSQ for ventricular (assist) bypass devices in the cardiovascular specialty. The stated change is the addition of new top case critical dimensions to be measured, together with a new measurement gauge. The supplement reason is listed as a process change involving the manufacturer, sterilizer, packager or supplier, and the supplement type is a 30-Day Notice.
The S135 identifier establishes that this is a supplement to the existing P160054 approval, not a new approval of the HeartMate 3 system. The record does not specify which dimensions, which gauge, which manufacturing site, or the original scope of the parent PMA. The stated purpose is a measurement change; the entry does not itself establish safety or clinical effectiveness, and no clinical conclusion should be drawn from it alone.
FDA approval order statement
addition of new top case critical dimensions to be measured and a new measurement gauge
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 1, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160054/S135
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- DSQ
- Decision code
- OK30
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
- Applicant
- Abbott Medical
- Product code
- DSQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160054. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160054 · Original PMA
HeartMate 3 Left Ventricular Assist System
P160054/S135 received
Application receipt date recorded by FDA.
P160054/S134 · Related supplement
HeartMate 3 Left Ventricular Assist System
P160054/S135 · FDA decision
30-Day Notice
P160054/S136 · Related supplement
HeartMate 3 Left Ventricular Assist System
Timeline entries are records held by MedtechLedger for P160054. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160054
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | Aug 23, 2017 | FDA | |
HeartMate 3 Left Ventricular Assist SystemP160054/S134 | ABBOTT MEDICAL | PMA supplement | Sep 9, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P160054/S135
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



